SCHEMBL18637029

SCHEMBL18637029

C=C(O)/C=C\C(=C)c1ccc(O)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.48
▸ HSD17B10 Q99714 3/20 0.48
▸ HTT P42858 2/20 0.48
▸ GFER P55789 1/20 0.48
▸ GPR55 Q9Y2T6 1/20 0.48
▸ KMT2A Q03164 5/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ CA12 O43570 2/20 0.41
▸ CA1 P00915 2/20 0.41
▸ CA2 P00918 2/20 0.41
▸ CA3 P07451 2/20 0.41
▸ TYR P14679 2/20 0.41
▸ CA4 P22748 2/20 0.41
▸ CA5A P35218 2/20 0.41
▸ CA9 Q16790 2/20 0.41
▸ CA14 Q9ULX7 2/20 0.41
▸ CA5B Q9Y2D0 2/20 0.41
▸ DRD1 P21728 1/20 0.41
▸ CA6 P23280 1/20 0.41
▸ CA7 P43166 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12087611 0.77 MAPT (0.50) MAPTHSD17B10HTTGFERGPR55
SCHEMBL12453517 0.76 F3 (0.59) MAPTKMT2AALDH1A1CA12CA1
SCHEMBL14340575 0.76 MAPT (0.46) MAPTHSD17B10HTTGFERGPR55
SCHEMBL29323625 0.75 ESR1 (0.43) MAPTHSD17B10HTTGFERGPR55
SCHEMBL6368627 0.75 CYP1B1 (0.62) MAPTHSD17B10KMT2AALDH1A1CA12
SCHEMBL11295640 0.73 ALDH5A1 (0.56) MAPTHSD17B10HTTGFERGPR55
SCHEMBL3628327 0.71 MAPT (0.52) MAPTHSD17B10HTTGFERGPR55
SCHEMBL19596826 0.71 CPT1B (0.47) MAPTHSD17B10HTTGFERGPR55
SCHEMBL16067308 0.70 TYR (0.61) MAPTHSD17B10HTTGFERKMT2A
SCHEMBL5612054 0.69 MAPT (0.63) MAPTHSD17B10HTTGFERGPR55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11697770-B2 Liquid crystal composition, method for producing high-molecular weight liquid crystal compound, light absorption anisotropic film, laminate, and image display device FUJIFILM CORPORATION (JP) 2023-07-11 — — US disclosed
US-20210324272-A1 LIQUID CRYSTAL COMPOSITION, METHOD FOR PRODUCING HIGH-MOLECULAR WEIGHT LIQUID CRYSTAL COMPOUND, LIGHT ABSORPTION ANISOTROPIC FILM, LAMINATE, AND IMAGE DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2021-10-21 — — US disclosed
US-10303055-B2 Resist composition and method for forming resist pattern MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2019-05-28 — — US disclosed
US-10294183-B2 Compound, resin, material for forming underlayer film for lithography, underlayer film for lithography, pattern forming method, and method for purifying the compound or resin MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2019-05-21 — — US disclosed
EP-3279730-A1 RADIATION-SENSITIVE COMPOSITION, AMORPHOUS FILM, AND RESIST PATTERN-FORMATION METHOD Mitsubishi Gas Chemical Company, Inc. (JP) 2018-02-07 — — EP disclosed
US-20170075220-A1 RESIST COMPOSITION AND METHOD FOR FORMING RESIST PATTERN MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2017-03-16 — — US disclosed
US-20170073288-A1 COMPOUND, RESIN, MATERIAL FOR FORMING UNDERLAYER FILM FOR LITHOGRAPHY, UNDERLAYER FILM FOR LITHOGRAPHY, PATTERN FORMING METHOD, AND METHOD FOR PURIFYING THE COMPOUND OR RESIN MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2017-03-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10303055-B2 Resist composition and method for forming resist pattern HEATR1, ABCC1, HEATR6 MAPT 2111/4885HSD17B10 741/4885HTT 1585/4885
US-20170073288-A1 COMPOUND, RESIN, MATERIAL FOR FORMING UNDERLAYER FILM FOR LITHOGRAPHY, UNDERLAYER FILM FOR LITHOGRAPHY, PATTERN FORMING METHOD, AND METHOD FOR PURIFYING THE COMPOUND OR RESIN PRDM9, EBPL, CDH1 MAPT 1516/4885HSD17B10 2333/4885HTT 4053/4885
US-10294183-B2 Compound, resin, material for forming underlayer film for lithography, underlayer film for lithography, pattern forming method, and method for purifying the compound or resin PRDM9, EBPL, CDH1 MAPT 1516/4885HSD17B10 2333/4885HTT 4053/4885
US-20170075220-A1 RESIST COMPOSITION AND METHOD FOR FORMING RESIST PATTERN HEATR1, ABCC1, HEATR6 MAPT 2111/4885HSD17B10 741/4885HTT 1585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback